REPL
Replimune Group, Inc. · Healthcare
Chief Business Officer Pamela Esposito sold $135K of Replimune Group, Inc.
Sold$135,250
$27.05Price
5,000Shares
−4%Stake
What REPL did after the filing
Prices for REPL after this filing aren't in yet.
Traded Mon, Aug 31. Filed Tue, Sep 1, 1:13 PM ET, during the session. Not investment advice.